• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.

作者信息

Taylor David, Stewart Suzanne, Connolly Anne

机构信息

Pharmacy Department, Maudsley Hospital, London SE5 8AZ, United Kingdom.

出版信息

J Affect Disord. 2006 Oct;95(1-3):129-33. doi: 10.1016/j.jad.2006.04.026. Epub 2006 Jun 22.

DOI:10.1016/j.jad.2006.04.026
PMID:16797080
Abstract

AIMS AND METHOD

Withdrawal symptoms are associated with cessation of all antidepressants but particularly paroxetine and venlafaxine. We aimed to examine rates of withdrawal symptoms reported to a national medication helpline over seven and a half year period. All calls reporting symptoms of antidepressant withdrawal were noted from a retrospective examination of contemporaneous handwritten records.

RESULTS

Between October 1997 and March 2005, the national medication helpline received 22,422 calls of which 1753 (7.8%) concerned antidepressant discontinuation symptoms. Of these, 690 calls (39.36%) related to paroxetine and 252 (14.38%) to venlafaxine. Calls regarding paroxetine increased ten-fold in the month following a BBC 'Panorama' programme centring on problems associated with its use. Comparing number of calls with the number of prescriptions written over the same period revealed that MAOIs have the highest rate of reported reactions.

CLINICAL IMPLICATIONS

Withdrawal symptoms were reported with nearly all antidepressants but most commonly with paroxetine and venlafaxine. Television programmes reporting adverse consequences of drug therapy can greatly increase reporting of discontinuation reactions. The highest rate of reporting adverse discontinuation symptoms was for MAOIs.

摘要

相似文献

1
Antidepressant withdrawal symptoms-telephone calls to a national medication helpline.
J Affect Disord. 2006 Oct;95(1-3):129-33. doi: 10.1016/j.jad.2006.04.026. Epub 2006 Jun 22.
2
Antidepressant discontinuation: a review of the literature.抗抑郁药停药:文献综述
J Clin Psychiatry. 1997;58 Suppl 7:11-5; discussion 16.
3
Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.表现为“中风”的抗抑郁药停药(戒断)症状。
J Psychopharmacol. 2001 Jun;15(2):139-41. doi: 10.1177/026988110101500210.
4
Discontinuation symptoms in depression and anxiety disorders.抑郁和焦虑症中的停药症状。
Int J Neuropsychopharmacol. 2007 Feb;10(1):73-84. doi: 10.1017/S1461145705006358. Epub 2005 Dec 19.
5
Antidepressant withdrawal reactions.抗抑郁药撤药反应。
Am Fam Physician. 1997 Aug;56(2):455-62.
6
Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.同一患者在九年后出现了类似的因停用中等剂量帕罗西汀和文拉法辛而产生的戒断症状。
J Psychopharmacol. 2008 Jul;22(5):581-4. doi: 10.1177/0269881107081562. Epub 2008 Jan 21.
7
Newer antidepressants and the discontinuation syndrome.新型抗抑郁药与停药综合征。
J Clin Psychiatry. 1997;58 Suppl 7:17-21; discussion 22.
8
Should children take antidepressants?儿童应该服用抗抑郁药吗?
Harv Ment Health Lett. 2003 Dec;20(6):5-7.
9
[Taperingstrips for paroxetine and venlafaxine].[帕罗西汀和文拉法辛的逐渐减量方案]
Tijdschr Psychiatr. 2013;55(10):789-94.
10
Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.比较文拉法辛缓释剂、米氮平、帕罗西汀治疗难治性抑郁症的疗效和耐受性:一项中国人群双盲、随机、先导研究。
J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

引用本文的文献

1
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.抗抑郁药戒断症状的发生率及危险因素:一项荟萃分析与系统评价
Mol Psychiatry. 2025 May;30(5):1758-1769. doi: 10.1038/s41380-024-02782-4. Epub 2024 Oct 11.
2
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.评估从已发表数据综述中得出的抗抑郁药撤药风险。
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
3
Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.
停用抗抑郁药后的迁延性戒断综合征:来自一个大型网络论坛的消费者叙述的描述性定量分析
Ther Adv Psychopharmacol. 2020 Dec 24;10:2045125320980573. doi: 10.1177/2045125320980573. eCollection 2020.
4
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review.新型精神活性物质(NPS)背景下的处方药滥用:一项系统综述
Brain Sci. 2018 Apr 22;8(4):73. doi: 10.3390/brainsci8040073.
5
Is There a Potential of Misuse for Venlafaxine and Bupropion?文拉法辛和安非他酮有被滥用的可能性吗?
Front Pharmacol. 2018 Mar 21;9:239. doi: 10.3389/fphar.2018.00239. eCollection 2018.
6
Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies.阿戈美拉汀的抗抑郁疗效:已发表和未发表研究的荟萃分析。
BMJ. 2014 Mar 19;348:g1888. doi: 10.1136/bmj.g1888.
7
An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme.一个药品不良反应诊所:为药物警戒计划注入新活力。
J Pharmacol Pharmacother. 2012 Jan;3(1):74-5. doi: 10.4103/0976-500X.92501.
8
Uncontrolled self-medication with venlafaxine in a patient with major depressive disorder.患者患有重度抑郁症,自行服用文拉法辛,未遵医嘱。
Psychiatry Investig. 2011 Mar;8(1):74-6. doi: 10.4306/pi.2011.8.1.74. Epub 2010 Dec 31.
9
Escitalopram--translating molecular properties into clinical benefit: reviewing the evidence in major depression.依地普仑——将分子特性转化为临床获益:重度抑郁症中的证据回顾。
J Psychopharmacol. 2010 Aug;24(8):1143-52. doi: 10.1177/0269881109349835. Epub 2010 Feb 10.
10
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.媒体关注后比较患者和医疗保健专业人员的药品不良反应报告:以荷兰一档关于他汀类药物利弊的电视节目播出为例
Br J Clin Pharmacol. 2009 May;67(5):558-64. doi: 10.1111/j.1365-2125.2009.03400.x. Epub 2009 Feb 26.